Probiotic and prebiotic supplements for digestive health after chronic spinal cord injury
Official title: The Effect of Probiotic and Prebiotic Supplementation on Gastrointestinal Health in Individuals With Chronic Spinal Cord Injury: A Randomized Controlled Crossover Trial
Run by Swiss Paraplegic Research, Nottwil · NCT06870331 · Data updated 2026-11-12
This trial will test whether taking a probiotic or a prebiotic can improve digestive symptoms, gut microbiome balance, inflammation, and transit time in adults with long-term spinal cord injury.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Swiss Paraplegic Research, Nottwil Research network |
| Locations | 1 site (Nottwil, Canton of Lucerne) |
| Status | Recruiting |
| Started | August 11, 2025 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | October 3, 2025 |
| Trial ID | NCT06870331 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with chronic (>1 year) spinal cord injury (para- or tetraplegia, AIS A–D) who have significant gastrointestinal complaints (GIQLI score below 110) and can attend the study center are ideal candidates.
✕Probably not a fit
People who recently used antibiotics, made major diet changes within four weeks, have active inflammatory bowel disease or other significant gastrointestinal disorders, or are on certain immunomodulating medications are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center crossover interventional trial enrolls adults with chronic spinal cord injury who report significant gastrointestinal complaints. Participants will take either a probiotic or a prebiotic daily for eight weeks, have a four-week washout, then take the other supplement for eight weeks, with four study visits for measurements. Outcomes include gastrointestinal symptom scores, gut microbiome composition, inflammatory serum markers, and gastrointestinal transit time. The study is conducted at Swiss Paraplegic Research in Nottwil and excludes recent antibiotic use or major recent dietary changes.
Why it matters
Potential benefit: If successful, the supplements could reduce gastrointestinal symptoms, favorably change the gut microbiome, lower inflammatory markers, and improve bowel transit for people with chronic spinal cord injury.
How similar studies have gone: Some prior studies in other populations show probiotics or prebiotics can alter the microbiome and improve gut symptoms, but evidence specific to chronic spinal cord injury is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (at screening): * Age: ≥ 18 years * Sex: male and female. * Chronic SCI (\>1 year post-injury) * Individuals with para- and tetraplegia (American Spinal Cord Injury (ASIA) Impairment Scale (AIS) score A-D) * Having significant gastrointestinal complaints, indicated with "yes" at screening and by a GIQLI questionnaire score below 110 at baseline * Signed written informed consent Exclusion Criteria (at screening): * Antibiotic use within the last four weeks before starting the study * Major dietary changes within the last four weeks before starting the study, such as initiating a vegan or ketogenic diet * Presence of clinically relevant medical conditions, including Crohn's disease, diagnosed eating or gastrointestinal disorders, assessed on an individual basis * Intake of significant concomitant medication, including immunomodulating therapy, mesalazines, or steroids, assessed on an individual basis * Concurrent participation in other clinical trials investigating or potentially affecting GI health * Insufficient German language skills to follow the study procedures * Pregnancy (anamnestic)
Where it's running
-
Swiss Paraplegic Research
Nottwil, Canton of Lucerne, Switzerland Recruiting
Study contacts
- Study coordinator: Claudio Perret, Prof. Dr.
- Email: claudio.perret@paraplegie.ch
- Phone: +41419396650
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
tSCS with rehabilitation for improving movement after spinal cord injury
This study tests whether adding rehabilitation training to transcutaneous spinal cord stimulation helps paraplegic patients regain voluntary movement after spinal cord injury.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Biomechanical and Perceived Effort in Manual Wheelchair Propulsion
This study tests whether combining objective shoulder loading data with how hard people feel they’re working can reveal how difficult manual wheelchair propulsion is for users with spinal cord injury.
-
Shockwave therapy added to toxin injections to help spasticity after spinal cord injury
Aims to see if focused shockwave therapy plus Botox injections reduce spasticity better than Botox alone in adults with spinal cord injury.
-
Vibratory Genital Nerve Stimulation to Help Female Sexual Function After Spinal Cord Injury
This study tests whether a home-use vibration device can improve sexual function in cisgender women with spinal cord injury by increasing genital blood flow during arousal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.